• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Leukoc Biol . T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe d

tetano

Editor, Senior Moderator
J Leukoc Biol


. 2021 Feb 2.
doi: 10.1002/JLB.4COVA1020-703R. Online ahead of print.
T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death


Brahim Belaid[SUP] 1 [/SUP], Lydia Lamara Mahammad[SUP] 1 [/SUP], Belgacem Mihi[SUP] 2 [/SUP], Sarah Yasmine Rahali[SUP] 1 [/SUP], Asma Djidjeli[SUP] 1 [/SUP], Zineb Larab[SUP] 1 [/SUP], Lilya Berkani[SUP] 1 [/SUP], Ismahane Berkane[SUP] 1 [/SUP], Wafa Sayah[SUP] 1 [/SUP], Fatma Merah[SUP] 1 [/SUP], Nouzha Zhor Lazli[SUP] 1 [/SUP], Lylia Kheddouci[SUP] 1 [/SUP], Ahmed Kadi[SUP] 3 [/SUP], Mourad Ouali[SUP] 4 [/SUP], Rachida Khellafi[SUP] 5 [/SUP], Dalila Mekideche[SUP] 6 [/SUP], Assia Kheliouen[SUP] 3 [/SUP], Soraya Ayoub[SUP] 7 [/SUP], R?da Malek Hamidi[SUP] 4 [/SUP], Fawzi Derrar[SUP] 8 [/SUP], Merzak Gharnaout[SUP] 9 [/SUP], Ines Allam[SUP] 1 [/SUP], R?da Djidjik[SUP] 1 [/SUP]



Affiliations

Abstract

The immune system plays a crucial role in the response against severe acute respiratory syndrome coronavirus 2 with significant differences among patients. The study investigated the relationships between lymphocyte subsets, cytokines, and disease outcomes in patients with coronavirus disease 2019 (COVID-19). The measurements of peripheral blood lymphocytes subsets and cytokine levels were performed by flow cytometry for 57 COVID-19 patients. Patients were categorized into two groups according to the severity of the disease (nonsevere vs. severe). Total lymphocytes, T cells, CD4+ T cells, CD8+ T cells, B cells, and natural killer cells were decreased in COVID-19 patients and statistical differences were found among different severity of illness and survival states (P ˂ 0.01). The levels of IL-6 and IL-10 were significantly higher in severe and death groups and negatively correlated with lymphocyte subsets counts. The percentages of Th17 in the peripheral blood of patients were higher than those of healthy controls whereas the percentages of Th2 were lower. For the severe cases, the area under receiver operating characteristic (ROC) curve of IL-6 was the largest among all the immune parameters (0.964; 95% confidence interval: 0.927-1.000, P < 0.0001). In addition, the preoperative IL-6 concentration of 77.38 pg/ml was the optimal cutoff value (sensitivity: 84.6%, specificity: 100%). Using multivariate logistic regression analysis and ROC curves, IL-6 > 106.44 pg/ml and CD8+ T cell counts <150 cells/μl were found to be associated with mortality. Measuring the immune parameters and defining a risk threshold can segregate patients who develop a severe disease from those with a mild pathology. The identification of these parameters may help clinicians to predict the outcome of the patients with high risk of unfavorable progress of the disease.

Keywords: COVID-19; SARS-CoV2; cytokines; flow cytometry; lymphocytes; prognosis.
 
Back
Top Bottom